Clinical trial / 2016
Garlic powder supplementation significantly reduced body weight and body fat mass in patients with nonalcoholic fatty liver disease.
In this trial, 110 subjects with NAFLD were randomly assigned to receive either two garlic tablets daily (containing 400 mg of garlic powder) or placebo tablets. The intervention group demonstrated significant reductions in body weight and body fat mass (P < 0.05). Percentage change in body weight was significantly greater in the intervention group compared to the control group (-2.6 vs. -0.7, P = 0.02). Neither group showed significant changes in total body water or lean body mass (P > 0.05), and no serious side effects were reported.
- Study type
- Randomized, double-blind, placebo-controlled trial
- Who was studied
- 110 subjects with nonalcoholic fatty liver disease (NAFLD)
- What was measured
- Body weight and body composition (body fat mass, total body water, lean body mass)
THE PAPER
Effect of garlic powder consumption on body composition in patients with nonalcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial.
Soleimani D, Paknahad Z, Askari G, Iraj B, Feizi A. Adv Biomed Res, 2016.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.